| Dr Paul Joseph Scheel Jr, MD | |
|
4921 Parkview Pl, Div Im Nephrology, Ste 5c, Saint Louis, MO 63110-1032 | |
| (314) 362-7603 | |
| (314) 362-5470 |
| Full Name | Dr Paul Joseph Scheel Jr |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 37 Years |
| Location | 4921 Parkview Pl, Saint Louis, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669404703 | NPI | - | NPPES |
| 200047799 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 2017025870 (Missouri) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Washington University | 9830008770 | 2506 |
News Archive
A new review suggests that low-dose birth control pills, which are generally considered to be safer than the pill of the past, still carries an increased risk for heart attack and stroke.
A new comprehensive study details a novel test for Zika virus, which utilizes saliva for rapid identification of the diagnostic markers of the virus.
New research published today in the journal eLife has demonstrated a new method for observing the behaviour of the protein Dystrophin in a living animal cell, in real-time. This breakthrough may provide a key to understanding how to treat the genetic disease, Muscular Dystrophy.
Genervon Biopharmaceuticals announced today that the U.S. Food and Drug Administration has granted an "orphan drug" designation to Genervon's GM604 (a.k.a. GM6) bio-drug for the treatment of Amyotrophic Lateral Sclerosis (ALS). The FDA also granted GM604 a "fast-track" designation for ALS in 2013.
› Verified 1 days ago
| Entity Name | Washington University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992746903 PECOS PAC ID: 9830008770 Enrollment ID: O20031119000372 |
News Archive
A new review suggests that low-dose birth control pills, which are generally considered to be safer than the pill of the past, still carries an increased risk for heart attack and stroke.
A new comprehensive study details a novel test for Zika virus, which utilizes saliva for rapid identification of the diagnostic markers of the virus.
New research published today in the journal eLife has demonstrated a new method for observing the behaviour of the protein Dystrophin in a living animal cell, in real-time. This breakthrough may provide a key to understanding how to treat the genetic disease, Muscular Dystrophy.
Genervon Biopharmaceuticals announced today that the U.S. Food and Drug Administration has granted an "orphan drug" designation to Genervon's GM604 (a.k.a. GM6) bio-drug for the treatment of Amyotrophic Lateral Sclerosis (ALS). The FDA also granted GM604 a "fast-track" designation for ALS in 2013.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Paul Joseph Scheel Jr, MD Po Box 60352, Saint Louis, MO 63160-0352 Ph: (314) 362-7603 | Dr Paul Joseph Scheel Jr, MD 4921 Parkview Pl, Div Im Nephrology, Ste 5c, Saint Louis, MO 63110-1032 Ph: (314) 362-7603 |
News Archive
A new review suggests that low-dose birth control pills, which are generally considered to be safer than the pill of the past, still carries an increased risk for heart attack and stroke.
A new comprehensive study details a novel test for Zika virus, which utilizes saliva for rapid identification of the diagnostic markers of the virus.
New research published today in the journal eLife has demonstrated a new method for observing the behaviour of the protein Dystrophin in a living animal cell, in real-time. This breakthrough may provide a key to understanding how to treat the genetic disease, Muscular Dystrophy.
Genervon Biopharmaceuticals announced today that the U.S. Food and Drug Administration has granted an "orphan drug" designation to Genervon's GM604 (a.k.a. GM6) bio-drug for the treatment of Amyotrophic Lateral Sclerosis (ALS). The FDA also granted GM604 a "fast-track" designation for ALS in 2013.
› Verified 1 days ago
Dr. Isik Turker, MD Nephrology Medicare: Medicare Enrolled Practice Location: 4921 Parkview Pl, Div Im Cardiology, Ste 8b, Saint Louis, MO 63110 Phone: 314-362-1291 Fax: 314-362-4278 | |
Conor Mccartney, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 915 N Grand Blvd, Saint Louis, MO 63106 Phone: 314-652-4100 | |
Dr. Faris Adam Bakeer, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1 Barnes Jewish Hospital Plz, Div Im Hospitalist, Saint Louis, MO 63110 Phone: 314-362-1700 Fax: 314-362-9878 | |
Rehan Rais, M.D. M.B.,B.S. Nephrology Medicare: Medicare Enrolled Practice Location: 660 S Euclid Ave, Saint Louis, MO 63110 Phone: 314-362-5000 | |
Nathan Farkas, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 1 Barnes Jew Hosp Plz, Saint Louis, MO 63110 Phone: 314-362-1930 | |
Dr. Nicole Foley, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110 Phone: 314-362-5000 | |
Soumojit Ghosh, Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3660 Vista Ave, Saint Louis, MO 63110 Phone: 314-977-6100 Fax: 314-977-6164 |